Mitesco Reports No Revenue and Significant Losses in Latest 10-Q Filing

Mitesco, Inc. reported significant financial challenges in its latest 10-Q filing for the quarter ending March 31, 2026. The company recorded no revenue during this period, a stark contrast to the $17,000 generated in the same quarter of the previous year. Operating expenses increased to $352,929, up from $283,986 year-over-year, leading to a net loss of $777,289 compared to a net income of $3,450,336 in the prior year. The loss per share for the quarter was $(0.05), compared to earnings of $0.35 per share in the same quarter of 2025.

The company's financial position has deteriorated, with total current assets dropping to $31,429 from $132,108 at the end of the previous fiscal year. Current liabilities increased slightly to $19.5 million, resulting in a total liabilities figure of $23.9 million. The stockholders' deficit also widened to $(23.9 million) from $(23.5 million) as of December 31, 2025. The filing indicates that the company is facing substantial doubt about its ability to continue as a going concern, primarily due to its lack of revenue generation and the need for additional funding.

Strategically, Mitesco has shifted its focus from operating clinics to developing technology and services through its new subsidiaries, Centcore, LLC and Vero Technology Ventures, LLC. Centcore is aimed at providing data center services, while VTV is exploring investment opportunities in cloud computing and artificial intelligence. The company has also initiated the development of an AI-based application called "Robo Agent," expected to be available for initial users in the third quarter of fiscal 2026. However, the transition has not yet yielded financial results, as indicated by the absence of revenue.

Operationally, Mitesco has seen a significant reduction in its workforce and has closed its clinic operations due to profitability issues. The company had six operating clinics in 2022 but has since ceased these operations. The filing notes that the majority of the holders of Series D and F Preferred stock, as well as other creditors, have been compensated with restricted common stock or Series A Preferred shares in exchange for their previous obligations. As of March 31, 2026, the company had cash and cash equivalents of only $1,533, raising concerns about its liquidity.

Looking ahead, Mitesco's management acknowledges the need for additional capital to execute its business plan and sustain operations. The company has not secured any formal agreements for funding as of the date of the filing, which raises further uncertainty about its future. The ongoing development of its new business units and technology offerings will be critical for Mitesco to regain financial stability and generate revenue in the coming quarters.